CSPC Pharmaceutical Group Limited (CSPCY)
OTCMKTS · Delayed Price · Currency is USD
4.140
+0.090 (2.22%)
Jun 4, 2025, 3:13 PM EDT

CSPC Pharmaceutical Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
27,04129,00931,45030,93727,86724,942
Upgrade
Revenue Growth (YoY)
-16.49%-7.76%1.66%11.02%11.73%12.84%
Upgrade
Cost of Revenue
8,5338,7119,2738,6806,7326,257
Upgrade
Gross Profit
18,50820,29922,17722,25621,13518,685
Upgrade
Selling, General & Admin
8,3389,74210,33011,51011,45310,323
Upgrade
Research & Development
5,3245,1914,8303,9873,4332,890
Upgrade
Operating Expenses
13,66214,93315,16115,49714,88613,213
Upgrade
Operating Income
4,8475,3667,0166,7606,2495,472
Upgrade
Interest Expense
-44.31-43.67-25.9-24.89-7.66-12.23
Upgrade
Interest & Investment Income
232.5232.5259.88242.53183.24102.82
Upgrade
Earnings From Equity Investments
-50.81-89.47-54.2-15.422.4413.53
Upgrade
Currency Exchange Gain (Loss)
19.7919.79102.53118.13-35.96-127.47
Upgrade
Other Non Operating Income (Expenses)
440.72221.31246.21315.32172.6343.17
Upgrade
EBT Excluding Unusual Items
5,4445,7077,5457,3956,5845,492
Upgrade
Gain (Loss) on Sale of Investments
-104.47-104.47-90.62266.41323.94625.99
Upgrade
Gain (Loss) on Sale of Assets
-23.4-23.4-22.23-7.36-10.79283.48
Upgrade
Asset Writedown
---42.32-72.11-50-
Upgrade
Other Unusual Items
------10.42
Upgrade
Pretax Income
5,3175,5797,3897,5826,8476,391
Upgrade
Income Tax Expense
1,1131,2401,3171,3501,1591,162
Upgrade
Earnings From Continuing Operations
4,2044,3396,0736,2325,6885,229
Upgrade
Minority Interest in Earnings
-10.56-10.79-199.37-140.66-82.94-69.36
Upgrade
Net Income
4,1934,3285,8736,0915,6055,160
Upgrade
Net Income to Common
4,1934,3285,8736,0915,6055,160
Upgrade
Net Income Growth
-30.78%-26.31%-3.58%8.67%8.63%38.92%
Upgrade
Shares Outstanding (Basic)
11,63711,73811,87211,91711,95311,955
Upgrade
Shares Outstanding (Diluted)
11,63711,73811,87311,91911,95411,956
Upgrade
Shares Change (YoY)
-1.85%-1.14%-0.38%-0.29%-0.01%-0.00%
Upgrade
EPS (Basic)
0.360.370.490.510.470.43
Upgrade
EPS (Diluted)
0.360.370.490.510.470.43
Upgrade
EPS Growth
-29.48%-25.47%-3.21%9.00%8.64%38.92%
Upgrade
Free Cash Flow
-2,5192,5555,4073,2265,383
Upgrade
Free Cash Flow Per Share
-0.210.210.450.270.45
Upgrade
Dividend Per Share
0.2440.2440.2580.1910.1520.107
Upgrade
Dividend Growth
-5.30%-5.30%35.08%25.66%41.58%13.25%
Upgrade
Gross Margin
68.44%69.97%70.51%71.94%75.84%74.91%
Upgrade
Operating Margin
17.92%18.50%22.31%21.85%22.43%21.94%
Upgrade
Profit Margin
15.51%14.92%18.68%19.69%20.11%20.69%
Upgrade
Free Cash Flow Margin
-8.69%8.12%17.48%11.58%21.58%
Upgrade
EBITDA
5,9736,4517,9347,6116,9746,156
Upgrade
EBITDA Margin
22.09%22.24%25.23%24.60%25.02%24.68%
Upgrade
D&A For EBITDA
1,1271,085918.47851.62724.39683.74
Upgrade
EBIT
4,8475,3667,0166,7606,2495,472
Upgrade
EBIT Margin
17.92%18.50%22.31%21.85%22.43%21.94%
Upgrade
Effective Tax Rate
20.93%22.23%17.82%17.81%16.93%18.18%
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.